Pulse Explorar nav.journalClub Debates Tendencias Investigadores Revistas

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

July 23, 2021Open Access

Molidustat for Japanese Patients With Renal Anemia Receiving Dialysis

TATadao AkizawaShowa University TYTakashi YamadaOsaka University of Pharmaceutical Sciences KNKiyoshi NoboriTokyo Medical and Dental University

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Molidustat maintained Hb levels throughout the trial in patients receiving dialysis and previously treated with erythropoiesis-stimulating agents, and was noninferior to darbepoetin.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Akizawa et al. (Fri,) studied this question.

synapsesocial.com/papers/69d774e3b843b2be9948fd8c https://doi.org/https://doi.org/10.1016/j.ekir.2021.07.015

Molidustat for Japanese Patients With Renal Anemia Receiving Dialysis | Synapse